A possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19 is proposed in a new article. James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of ...

Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.

The first study of its kind reports that patients should keep taking well-known heart medications. Patients with heart conditions that require angiotensin-converting enzyme (ACE) inhibitors and ...

Atrial fibrillation, or AFib, is the most common heart rhythm disorder. With AFib, the beating of the upper chambers of your heart (the atria) becomes irregular, and blood has a harder time reaching ...

Patients with heart failure who start taking sacubitril/valsartan (Entresto; Novartis) do not appear to have a greater risk of angioedema than do those who opt for an ACE inhibitor or ARB instead, an ...

UnitedHealth is spearheading a digital clinical trial to potentially repurpose a class of hypertension drugs to treat high-risk COVID-19 cases. Angiotensin-converting enzyme (ACE) inhibitors are a ...

The use of angiotensin-converting enzyme (ACE) inhibitors to lower blood pressure was associated with an overall increased risk for lung cancer of 14% compared to hypertension therapy with angiotensin ...

Angiotensin-converting enzyme (ACE) inhibitors, a class of drugs used to lower blood pressure, could also be protective against the decline in muscle strength in elderly women suggest authors of a ...

In this rapidly evolving setting, clinicians are weighing the alleged harm of continuing these medications in patients for whom ACE inhibitors and ARBs have known benefit against the harm to their ...

There is no consensus on when to introduce cardioprotective treatment in patients with Becker muscular dystrophy (BMD), and practice varies widely. A new study published in the Journal of ...